Pharma & Biotech

Iovance Biotherapeutics witnessed a dramatic upswing in its share price, climbing more than 20 percent in a single trading session....

Intellia Therapeutics faced a severe market downturn following the disclosure of a patient death in a pivotal Phase 3 clinical...

Ocugen's latest quarterly earnings report has triggered alarm bells across the investment community. The clinical-stage biopharmaceutical company reported a significantly...

A Canadian health technology firm is making waves with a staggering 354% revenue surge and comprehensive corporate restructuring. While Healwell...

Investors are delivering a harsh verdict on Redcare Pharmacy despite the company reporting exceptional operational results. The online pharmacy's stock...

The pharmaceutical industry is witnessing an intense bidding war as Pfizer competes against Danish rival Novo Nordisk for control of...

MannKind Corporation witnessed a substantial rally in its share price following the release of its third-quarter 2025 financial results, which...

Amgen has delivered a standout quarterly performance that has captured significant market attention. The biotechnology leader not only surpassed investor...

BioNTech presents investors with a complex financial picture marked by contradictory signals. The German biotech firm reported a substantial 22%...

A significant regulatory shift from China has injected fresh momentum into Illumina's stock, as the country removes its export prohibition...